Exploring Decisional Conflict Experienced by Individuals Considering Metoidioplasty and Phalloplasty Gender-affirming Surgery.


Journal

Plastic and reconstructive surgery. Global open
ISSN: 2169-7574
Titre abrégé: Plast Reconstr Surg Glob Open
Pays: United States
ID NLM: 101622231

Informations de publication

Date de publication:
May 2024
Historique:
received: 11 01 2024
accepted: 27 03 2024
medline: 31 5 2024
pubmed: 31 5 2024
entrez: 31 5 2024
Statut: epublish

Résumé

Metoidioplasty and phalloplasty gender-affirming surgery (MaPGAS) is increasingly performed and requires patients to make complex decisions that may lead to decisional uncertainty. This study aimed to evaluate decisional conflict in individuals considering MaPGAS. We administered a cross-sectional survey to adult participants assigned female sex at birth and considering MaPGAS, recruited via social media platforms and community health centers. We collected data on demographics, medical and surgical history, MaPGAS type considered, and the Decisional Conflict Scale (DCS). DCS scores range from 0 to 100 (>37.5 indicates greater decisional conflict). Demographic characteristics and DCS scores were compared between subgroups, using descriptive and chi-square statistics. Participants commented on MaPGAS uncertainty, and their comments were evaluated and thematically analyzed. Responses from 264 participants were analyzed: mean age 29 years; 64% (n = 168) trans men, 80% (n = 210) White, 78% (n = 206) nonrural, 45% (n = 120) privately insured, 56% (n = 148) had 4 or more years of college, 23% (n = 84) considering metoidioplasty, 24% (n = 87) considering phalloplasty, and 26% (n = 93) considering metoidioplasty and phalloplasty. DCS total scores were significantly higher (39.8; In a cross-sectional national sample of individuals seeking MaPGAS, decisional uncertainty was the highest for those considering both MaPGAS options compared with metoidioplasty or phalloplasty alone. This suggests this cohort would benefit from focused decision support.

Sections du résumé

Background UNASSIGNED
Metoidioplasty and phalloplasty gender-affirming surgery (MaPGAS) is increasingly performed and requires patients to make complex decisions that may lead to decisional uncertainty. This study aimed to evaluate decisional conflict in individuals considering MaPGAS.
Methods UNASSIGNED
We administered a cross-sectional survey to adult participants assigned female sex at birth and considering MaPGAS, recruited via social media platforms and community health centers. We collected data on demographics, medical and surgical history, MaPGAS type considered, and the Decisional Conflict Scale (DCS). DCS scores range from 0 to 100 (>37.5 indicates greater decisional conflict). Demographic characteristics and DCS scores were compared between subgroups, using descriptive and chi-square statistics. Participants commented on MaPGAS uncertainty, and their comments were evaluated and thematically analyzed.
Results UNASSIGNED
Responses from 264 participants were analyzed: mean age 29 years; 64% (n = 168) trans men, 80% (n = 210) White, 78% (n = 206) nonrural, 45% (n = 120) privately insured, 56% (n = 148) had 4 or more years of college, 23% (n = 84) considering metoidioplasty, 24% (n = 87) considering phalloplasty, and 26% (n = 93) considering metoidioplasty and phalloplasty. DCS total scores were significantly higher (39.8;
Conclusions UNASSIGNED
In a cross-sectional national sample of individuals seeking MaPGAS, decisional uncertainty was the highest for those considering both MaPGAS options compared with metoidioplasty or phalloplasty alone. This suggests this cohort would benefit from focused decision support.

Identifiants

pubmed: 38818233
doi: 10.1097/GOX.0000000000005840
pii: GOX-D-24-00035
pmc: PMC11139465
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e5840

Informations de copyright

Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.

Déclaration de conflit d'intérêts

Note: Scores range from 0 to 100; a higher score indicates a more negative outcome (greater decisional conflict, feeling more uncertain and less informed). Typically, a score <25 indicates no conflict and >37.5 associated with decisional conflict/delayed decisions.The authors have no financial interest to declare in relation to the content of this article. This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (R21DK124733-02S1).

Auteurs

Reade Otto-Moudry (R)

From the Geisel School of Medicine at Dartmouth, Hanover, N.H.

Linda M Kinney (LM)

The Center for Program Design and Evaluation (CPDE), The Dartmouth Institute, Hanover, N.H.

Rebecca L Butcher (RL)

The Center for Program Design and Evaluation (CPDE), The Dartmouth Institute, Hanover, N.H.

Gaines Blasdel (G)

University of Michigan Medical School, Ann Arbor, Mich.

Lee K Brown (LK)

Department of Surgery, Section of Urology, Dartmouth-Hitchcock Clinic, Lebanon, N.H.

Glyn Elwyn (G)

From the Geisel School of Medicine at Dartmouth, Hanover, N.H.
Coproduction Laboratory, The Dartmouth Institute, Hanover, N.H.

Jeremy B Myers (JB)

Division of Urology, Department of Surgery, University of Utah Health, Salt Lake City, Utah.

John H Turco (JH)

From the Geisel School of Medicine at Dartmouth, Hanover, N.H.
Department of Internal Medicine, Section of Endocrinology, Dartmouth-Hitchcock Clinic, Lebanon, N.H.

John F Nigriny (JF)

Department of Surgery, Section of Plastic Surgery, Dartmouth-Hitchcock Clinic, Lebanon, N.H.

Rachel A Moses (RA)

From the Geisel School of Medicine at Dartmouth, Hanover, N.H.
Department of Surgery, Section of Urology, Dartmouth-Hitchcock Clinic, Lebanon, N.H.

Classifications MeSH